Results of previous studies have shown that the activation of JNK and P38 is necessary for cancer cell death which is initiated by a variety of anti-cancer agents and that, notably, the JNK pathway plays an important role in the activation of the mitochondrial-dependent apoptotic pathway (49,50). Here, MAPK8 is linked to cancer.